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Summary: A micromethod is described for the determination of glucose in 20 μΐ of skin-puncture blood for the
DuPont aca. For the determination of glucose we prefer whole blood which is deproteinised with uranyl acetate.
Some modification of test conditions are programmed into the computer II. The emergency analysis of supernatant
on the aca then gives the same values as the Technicon Autoanalyzer II, using glucose dehydrogenase for routine
analyses. The aca readout is linearly related to glucose concentrations up to 60 mmol/1.
Mikromethode zur Bestimmung von Glucose in Kapillarblut mit dem DuPont aca
Zusammenfassung: Eine Mikromethode zur Bestimmung der Glucose in 20 μΐ Kapillarblut wird f r den DuPont aca
beschrieben. Wir bestimmen die Glucose in Vollblut nach Enteiwei ung mit Uranylacetat. Die Analyse des ber-
standes ergibt nach entsprechenden nderungen, die nur am Computer II auszuf hren sind, f r Notfalluntersuchun-
gen auf dem aca die gleichen Ergebnisse wie f r Routineuntersuchungen mittels Glucosedehydrogenase auf dem
Autoanalyzer II. Linearit t besteht f r den aca bis 60 mmol/1.
Introduction
We claim that the determination of glucose in skin-
puncture (capillary) blood is superior to the determ-
ination of glucose in serum or plasma; only the former
method is physiologically sound and logical (1,2,3).
The original aca glucose method is based on the analysis
of 40 μΐ serum using the hexokinase glucose-6-phosphate
dehydrogenase-method (4). In order to prevent systematic
differences in our results (5, 6) and different ways of
taking samples, the aca had to be integrated into our
system of sampling. Apparently two different approaches
are possible:
1. Deproteinisation of the samples with acidic reagents
(e.g. perchloric acid or perchloric acid/perchlprate) or
2. deproteinisation with neutral reagents (e.g. uranyl
acetate)
Our group preferred the second way, which appeared
easier, while another group independently verified the
first modification (7) using 50 μΐ of whole blood, as we
heard later.
Here we describe a method permitting determination of
glucose in only 20 μΐ of whole blood on the DuPont aca.
Materials and Methods
Procedure
20 μΐ of skin-puncture blood were deproteinised with 500 μΐ
of uranyl acetate solution (1.9 mmol/1) as described elsewhere
(3). After centrifugation (7500 gy l min) the supernatant was
ready for analysis, either in the aca or with the glucose de-
hydrogenase method on the Autoanalyzer II.
Apparatus
An Automatic Clinical Analyzer (aca) with computer II was
used (DuPont de Nemours Company, Wilmington, Delaware
19898, USA).
The following modifications were necessary and easy to realize:
1. The volume of diluent 1 was reduced from 4960 μΐ to
4600 μΐ according to the manufacturers' manuals (4). The
volume of supernatant aspirated by the aca was then 400 μΐ.
2. The theoretical scale factor (0.0448) was multiplied by our
dilution factor 2.6: the new scale factor was 0.1165.
3. The theoretical offset (-17) was corrected to -44. The new
starting point was 9956. Count-by and A/D offset remained
unchanged.
Readout units: The aca prints out in 1 mg/dl increments. No
further variations to the original aca procedure were necessary.
Calibration
Calibration was carried out with protein-containing (60 g/1)
glucose standards. We suggest calibration levels of 27. 8,16.7,
5.6 mmol/1 glucose. After deproteinisation with uranyl acetate
and centrifugation, calibration was performed in the usual
manner (4)'.
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Tab. 1. Accuracy, tested with commercially available sera
Serum
Monitroll(141 A)
Precinorm U (606)
Monitrol II (46B)
Assigned value (mmol/1)
4.37 (Hexokinase)
6.22 (Glucose dehydro1·
gen se)
12.0 (Hexokinase)
aca value (mmol/1)
4.33
6.28
11.94
No. of analyses
5
1?
5
Serum obtained from
Merz and Dade GmbH,
M nchen.
Boehringer Mannheim
GmbH.
Merz and Dade GmbH,
M nchen.
Results
Linearity and Accuracy
Linearity exists in the range of 0—60 mmol/1 glucose as
determined with glucose standards at levels of 0; 1.4,
2.8,9.7, 16.7, 27.8, 38.9,55.6 mmol/1. The method
yields a correlation coefficient of 0.999 with a regression
line of: y (aca) = 0.99x (standard) + 0.06.
Accuracy was tested with commercially available sera.
Table 1 lists the sera investigated and shows our results.
Interfering Substances
Experiments have shown that there is less interference
caused by hemolytic or icteric specimens in the new
method than in the original aca version. Hemolyzed
blood shows no significant interference up to 2.0 g/dl
hemoglobin per sample. Higher concentrations of
hemoglobin may give falsely depressed values. Icteric
samples show no significant interference up to 680
Aimol/1 bilirubin per sample and lipemic samples can
be analysed without significant interference up to
46 mmol/1 serum triglycerides. Serum protein con-
centrations from 40 g/1 up to 120 g/1 show no significant
influence on the results. Lower protein concentrations
may cause falsely elevated values.
Precision
Table 2 indicates good results for within-run and day-to-
day precision. The day-to-day imprecision encloses data
from five different lot nos. of test packs and is nearly the
same as that of the Autoanalyzer II.
Comparison of Methods
Results obtained by the present method were directly
compared with those obtained by the glucose dehydro-
genase method on the Technicon Autoanalyzer II (3,8).
Figure 1 shows the regression line y = byx - χ + yx
calculated from 61 data pairs. The slope is byx = 1.006
and the y-intercept is ayx = -0.045. The coefficient of
regression is r = 0.994.
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Fig. 1. Comparison for patients' specimens.
The reference method (glucose dehydrogenase on Technicon
Autoanalyzer II) is on the x-axis (mmol/1) and the aca method
is on the y-axis (mmol/1).
Statistical analysis:
No. of pairs: Ν = 61. Mean: χ = 9.95, y = 9.96 mmol/1.
Standard deviation: sx = 6.099, sy = 6.175 rhmpl/1.
Sx" = 0.794, sy· = 0.804 mmol/1.
Bias (ly - x l ) = 0.01 mmol/1.
Slope:
 Dyx= 1.006, bxy = 0.982.
y-intercept: ayx = -0.045, axy = 0.168 mmol/1.
Variance: Sxy = 2170.5 (mmol/l)?.
Covariance: Sxy = 37.42 (mmol/1)2.
Standard deviation of y about x: syjc = 0.698 mmol/1.
Correlation coefficient: r = 0.994.
T-test: t = 0.013, critical t value at P = 0.05 is 1.98; at P = 0.01
is 2.36.
Discussion
We have evaluated a microdetermination of glucose for
the DuPont aca based on 20 μΐ of whole, skin-puncture
blood. There are considerable practical advantages in
our method: The volume of samples is minimal and
easy to get, even from newborn children; no specially
trained personel are required.
20 /il of sample reduce systematic errors due to de-
proteinisation (volume displacement effects) to a
neglectable amount of 0.3%, thus permitting a cali-
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Tab. 2. Precision data.
Within-run precision data from glucose standards:
Mean (mmol/1) S.D. (mmol/1) C.V. < N
0.17
1.72
4.17
6.17
12.8
26.6
0.18
0.09
0.13
0.13
0.12
0.17
5.3
3.2
2.1
1.0
0.6
7
15
15
15
10
15
Day-to-day precision data from Monitrol II XPT 62 (Merz and
Dade, München):
Mean
(mmol/1)
12.6
12.6
S.D. C.V.
(mmol/1) (%)
0.3 2.2
0.2 1.6
N
(days)
161
164
Method
aca
(Hexo-
kinase)
AAII
(Glucose
dehydro-
genase)
S.D.: Standard deviation
C.V.: Coefficient of variation
N: Number of analyses resp. number of days.
Lot nos. of test packs: I 7094 A, I 7171 A, I 7215. A, I 7227 B,
I 7241 A.
bration of the aca with usual protein-containing
materials. Thus we can avoid determination of special
"aca-values" for reference materials as described in
I.e. (7). Such bottle values have to be obtained by split
sample comparison with a reference method, and they
may cause uncertainties.
In our opinion the choice of uranyl acetate instead of
acidic reagents for deproteinisation facilitates the
adaption of the aca to the described modification: Less
changes in the lacing diagramm of computer II have to
be carried out and no special buffer solutions have to
be prepared, which may cause complications with new
aca tests requiring a diluent 6. Last, but not least,
neither acidic nor corrosive reagents are aspirated by
the aca in our modification.
The clinical validy of the method is documented by an
increased range of linearity compared to (4,7), good
coefficients of variation even at low, pathological
levels, less interference due to glycolysis by red and
white blood cells, icteric or lipemic samples, and results
which show no systematic differences to an Auto-
analyzer II method based on glucose dehydrogenase.
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